A systematic comparison of pan-Trk immunohistochemistry assays across multiple cancer types.

Given the therapeutic importance, testing for NTRK rearrangements in daily practice has become necessary and despite IHC being a fast and affordable tool, using it in routine diagnostics is complicated and requires a high level of expertise.